Annual Income Statements for SuRo Capital Corp. 6.00% Notes due 2026
Annual Income Statements for SuRo Capital Corp. 6.00% Notes due 2026
This table shows SuRo Capital Corp. 6.00% Notes due 2026's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.
Quarterly Income Statements for SuRo Capital Corp. 6.00% Notes due 2026
This table shows SuRo Capital Corp. 6.00% Notes due 2026's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.
| Metric |
|
Q1 2024 |
Q2 2024 |
Q3 2024 |
Q4 2024 |
Q1 2025 |
Q2 2025 |
Q3 2025 |
Q4 2025 |
Q1 2026 |
Q2 2026 |
Q3 2026 |
| Net Income / (Loss) Attributable to Common Shareholders |
|
-22 |
-11 |
-5.45 |
0.04 |
-0.81 |
62 |
2.78 |
-20 |
156 |
-19 |
-24 |
| Consolidated Net Income / (Loss) |
|
-3.22 |
-3.66 |
-3.21 |
-3.86 |
-3.66 |
-3.72 |
2.78 |
-5.67 |
-3.98 |
-23 |
-24 |
| Net Income / (Loss) Continuing Operations |
|
-3.22 |
-3.66 |
-3.21 |
-3.86 |
-3.66 |
-3.72 |
2.78 |
-5.67 |
-3.98 |
-23 |
-24 |
| Total Pre-Tax Income |
|
-3.22 |
-3.66 |
-3.21 |
-3.86 |
-3.66 |
-3.72 |
2.78 |
-5.67 |
-3.98 |
-23 |
-24 |
| Total Revenue |
|
1.53 |
1.03 |
0.89 |
1.23 |
0.50 |
0.17 |
7.40 |
0.56 |
0.73 |
0.30 |
-19 |
| Net Interest Income / (Expense) |
|
0.00 |
0.00 |
0.00 |
- |
0.00 |
0.00 |
0.46 |
- |
0.00 |
0.00 |
0.27 |
| Total Interest Income |
|
0.00 |
0.00 |
0.00 |
- |
0.00 |
0.00 |
0.46 |
- |
0.00 |
0.00 |
0.27 |
| Investment Securities Interest Income |
|
0.00 |
0.00 |
0.00 |
- |
0.00 |
0.00 |
0.46 |
- |
0.00 |
0.00 |
0.27 |
| Total Interest Expense |
|
0.00 |
0.00 |
0.00 |
- |
0.00 |
0.00 |
0.00 |
- |
0.00 |
0.00 |
0.00 |
| Total Non-Interest Income |
|
1.53 |
1.03 |
0.89 |
1.23 |
0.50 |
0.17 |
6.94 |
0.56 |
0.73 |
0.30 |
-20 |
| Net Realized & Unrealized Capital Gains on Investments |
|
- |
- |
- |
- |
- |
- |
6.94 |
- |
- |
- |
-20 |
| Total Non-Interest Expense |
|
4.75 |
4.68 |
4.10 |
5.09 |
4.16 |
3.89 |
4.62 |
6.23 |
4.71 |
24 |
4.47 |
| Other Operating Expenses |
|
2.57 |
2.48 |
2.18 |
2.23 |
2.49 |
2.32 |
4.62 |
2.32 |
2.73 |
3.96 |
4.47 |
| Income Tax Expense |
|
- |
- |
- |
- |
- |
- |
0.00 |
- |
- |
- |
0.00 |
| Basic Earnings per Share |
|
($0.87) |
($0.45) |
($0.23) |
($0.05) |
($0.03) |
$2.63 |
$0.30 |
($0.89) |
$6.13 |
($0.72) |
($0.80) |
| Weighted Average Basic Shares Outstanding |
|
25.39M |
23.41M |
23.38M |
23.90M |
23.57M |
23.73M |
24.37M |
24.23M |
25.38M |
25.98M |
26.47M |
| Diluted Earnings per Share |
|
($0.87) |
($0.45) |
($0.23) |
($0.05) |
($0.03) |
$2.23 |
$0.28 |
($0.70) |
$5.18 |
($0.72) |
($0.80) |
| Weighted Average Diluted Shares Outstanding |
|
25.39M |
23.41M |
23.38M |
23.90M |
23.57M |
28.24M |
28.99M |
28.79M |
30.16M |
25.98M |
26.47M |
| Weighted Average Basic & Diluted Shares Outstanding |
|
23.35M |
23.38M |
23.38M |
23.55M |
23.55M |
23.89M |
25.12M |
25.39M |
26.07M |
26.47M |
26.47M |
Annual Cash Flow Statements for SuRo Capital Corp. 6.00% Notes due 2026
This table details how cash moves in and out of SuRo Capital Corp. 6.00% Notes due 2026's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.
| Metric |
|
2020 |
2021 |
2022 |
2023 |
2024 |
2025 |
| Net Change in Cash & Equivalents |
|
0.93 |
153 |
-158 |
-12 |
-8.14 |
29 |
| Net Cash From Operating Activities |
|
-24 |
184 |
-111 |
2.38 |
2.37 |
34 |
| Net Cash From Continuing Operating Activities |
|
-24 |
184 |
-111 |
2.38 |
2.37 |
34 |
| Net Income / (Loss) Continuing Operations |
|
75 |
147 |
-132 |
5.07 |
-38 |
49 |
| Consolidated Net Income / (Loss) |
|
75 |
147 |
-132 |
5.07 |
-38 |
49 |
| Amortization Expense |
|
0.38 |
0.09 |
0.43 |
0.32 |
0.54 |
0.48 |
| Non-Cash Adjustments to Reconcile Net Income |
|
-188 |
170 |
21 |
-3.32 |
41 |
-16 |
| Changes in Operating Assets and Liabilities, net |
|
89 |
-134 |
0.43 |
0.31 |
-0.63 |
0.54 |
| Net Cash From Investing Activities |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Net Cash From Continuing Investing Activities |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Net Cash From Financing Activities |
|
25 |
-31 |
-48 |
-14 |
-11 |
-5.28 |
| Net Cash From Continuing Financing Activities |
|
25 |
-31 |
-48 |
-14 |
-11 |
-5.28 |
| Issuance of Debt |
|
0.00 |
75 |
0.00 |
0.00 |
30 |
5.00 |
| Issuance of Common Equity |
|
50 |
0.08 |
0.23 |
0.00 |
0.00 |
11 |
| Repayment of Debt |
|
0.00 |
-0.29 |
0.00 |
0.00 |
-30 |
-8.75 |
| Repurchase of Common Equity |
|
-10 |
0.00 |
-21 |
-14 |
-9.40 |
0.00 |
| Payment of Dividends |
|
-15 |
-103 |
-27 |
-0.14 |
-0.14 |
-12 |
| Other Financing Activities, Net |
|
-0.29 |
-2.34 |
-0.00 |
0.00 |
-1.08 |
-0.19 |
| Cash Interest Paid |
|
1.87 |
0.79 |
4.66 |
4.50 |
4.36 |
4.64 |
| Cash Income Taxes Paid |
|
0.01 |
0.04 |
0.08 |
0.53 |
0.09 |
-0.19 |
Quarterly Cash Flow Statements for SuRo Capital Corp. 6.00% Notes due 2026
This table details how cash moves in and out of SuRo Capital Corp. 6.00% Notes due 2026's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.
| Metric |
|
Q1 2024 |
Q2 2024 |
Q3 2024 |
Q4 2024 |
Q1 2025 |
Q2 2025 |
Q3 2025 |
Q4 2025 |
Q1 2026 |
Q2 2026 |
Q3 2026 |
| Net Change in Cash & Equivalents |
|
23 |
3.57 |
-22 |
-13 |
-3.86 |
34 |
4.70 |
-5.51 |
-5.76 |
-30 |
28 |
| Net Cash From Operating Activities |
|
23 |
13 |
-21 |
-12 |
-3.72 |
34 |
-0.10 |
4.40 |
-5.76 |
-24 |
8.23 |
| Net Cash From Continuing Operating Activities |
|
23 |
13 |
-21 |
-12 |
-3.72 |
34 |
-0.10 |
4.40 |
-5.76 |
-24 |
8.23 |
| Net Income / (Loss) Continuing Operations |
|
-22 |
-11 |
-5.45 |
0.04 |
-0.81 |
62 |
7.42 |
-20 |
156 |
-19 |
-21 |
| Consolidated Net Income / (Loss) |
|
-22 |
-11 |
-5.45 |
0.04 |
-0.81 |
62 |
7.42 |
-20 |
156 |
-19 |
-21 |
| Amortization Expense |
|
0.11 |
0.11 |
0.21 |
0.12 |
0.12 |
0.12 |
0.12 |
0.12 |
0.11 |
0.11 |
0.11 |
| Non-Cash Adjustments to Reconcile Net Income |
|
44 |
22 |
-16 |
-9.97 |
-4.14 |
-30 |
-8.02 |
27 |
-162 |
-6.23 |
29 |
| Changes in Operating Assets and Liabilities, net |
|
0.95 |
1.07 |
-0.00 |
-2.64 |
1.11 |
1.21 |
0.38 |
-2.15 |
0.92 |
0.74 |
-0.07 |
| Net Cash From Financing Activities |
|
-0.11 |
-9.40 |
-0.75 |
-0.25 |
-0.14 |
-0.03 |
4.80 |
-9.92 |
-0.00 |
-6.28 |
20 |
| Net Cash From Continuing Financing Activities |
|
-0.11 |
-9.40 |
-0.75 |
-0.25 |
-0.14 |
-0.03 |
4.80 |
-9.92 |
-0.00 |
-6.28 |
20 |
| Repayment of Debt |
|
0.00 |
- |
-25 |
-5.01 |
-4.94 |
- |
- |
-3.81 |
0.00 |
- |
-0.05 |
| Other Financing Activities, Net |
|
0.00 |
- |
-0.87 |
-0.21 |
-0.19 |
-0.03 |
0.03 |
-0.00 |
0.00 |
-0.09 |
-0.27 |
| Cash Interest Paid |
|
1.13 |
1.13 |
0.96 |
1.15 |
1.15 |
1.16 |
1.16 |
1.16 |
1.11 |
1.04 |
0.98 |
Annual Balance Sheets for SuRo Capital Corp. 6.00% Notes due 2026
This table presents SuRo Capital Corp. 6.00% Notes due 2026's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.
| Metric |
|
2021 |
2022 |
2023 |
2024 |
2025 |
| Total Assets |
|
462 |
284 |
278 |
232 |
276 |
| Cash and Due from Banks |
|
198 |
40 |
28 |
20 |
49 |
| Restricted Cash |
|
- |
- |
- |
0.00 |
0.04 |
| Loans and Leases, Net of Allowance |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Deferred Acquisition Cost |
|
0.62 |
0.56 |
0.59 |
0.53 |
0.51 |
| Other Assets |
|
263 |
159 |
249 |
211 |
226 |
| Total Liabilities & Shareholders' Equity |
|
389 |
284 |
278 |
232 |
276 |
| Total Liabilities |
|
97 |
74 |
74 |
74 |
71 |
| Accrued Interest Payable |
|
0.18 |
- |
- |
- |
0.00 |
| Long-Term Debt |
|
- |
73 |
74 |
73 |
70 |
| Other Long-Term Liabilities |
|
24 |
1.00 |
0.50 |
0.78 |
0.93 |
| Commitments & Contingencies |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Total Equity & Noncontrolling Interests |
|
365 |
210 |
203 |
158 |
205 |
| Total Preferred & Common Equity |
|
365 |
210 |
203 |
158 |
205 |
| Total Common Equity |
|
365 |
210 |
203 |
158 |
205 |
| Common Stock |
|
350 |
331 |
249 |
227 |
218 |
| Accumulated Other Comprehensive Income / (Loss) |
|
2.56 |
-124 |
-33 |
-52 |
-19 |
| Other Equity Adjustments |
|
12 |
2.55 |
-12 |
-17 |
6.87 |
Quarterly Balance Sheets for SuRo Capital Corp. 6.00% Notes due 2026
This table presents SuRo Capital Corp. 6.00% Notes due 2026's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.
| Metric |
|
Q3 2023 |
Q1 2024 |
Q2 2024 |
Q3 2024 |
Q1 2025 |
Q2 2025 |
Q3 2025 |
Q1 2026 |
Q2 2026 |
Q3 2026 |
| Total Assets |
|
289 |
257 |
238 |
234 |
232 |
295 |
308 |
433 |
420 |
419 |
| Cash and Due from Banks |
|
74 |
51 |
54 |
33 |
16 |
50 |
55 |
43 |
13 |
41 |
| Restricted Cash |
|
- |
- |
- |
- |
- |
0.04 |
0.04 |
0.00 |
0.00 |
0.00 |
| Loans and Leases, Net of Allowance |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Deferred Acquisition Cost |
|
0.61 |
0.58 |
0.56 |
0.49 |
0.54 |
0.56 |
0.52 |
0.50 |
0.58 |
0.16 |
| Other Assets |
|
195 |
176 |
183 |
201 |
215 |
0.81 |
253 |
389 |
407 |
378 |
| Total Liabilities & Shareholders' Equity |
|
289 |
257 |
238 |
234 |
232 |
295 |
308 |
433 |
420 |
399 |
| Total Liabilities |
|
77 |
75 |
76 |
76 |
75 |
76 |
77 |
72 |
64 |
84 |
| Accrued Interest Payable |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
0.27 |
| Long-Term Debt |
|
74 |
74 |
74 |
73 |
73 |
73 |
73 |
70 |
62 |
62 |
| Other Long-Term Liabilities |
|
3.35 |
1.32 |
2.05 |
3.03 |
1.61 |
2.28 |
3.04 |
1.84 |
2.11 |
1.37 |
| Commitments & Contingencies |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Total Equity & Noncontrolling Interests |
|
212 |
182 |
162 |
157 |
157 |
219 |
232 |
362 |
356 |
335 |
| Total Preferred & Common Equity |
|
212 |
182 |
162 |
157 |
157 |
219 |
232 |
362 |
356 |
335 |
| Total Common Equity |
|
212 |
182 |
162 |
157 |
157 |
219 |
232 |
362 |
356 |
335 |
| Common Stock |
|
319 |
249 |
240 |
241 |
227 |
227 |
238 |
218 |
231 |
231 |
| Accumulated Other Comprehensive Income / (Loss) |
|
-95 |
-67 |
-65 |
-57 |
-53 |
-11 |
-9.27 |
135 |
112 |
98 |
| Other Equity Adjustments |
|
-12 |
- |
-13 |
-27 |
-17 |
3.77 |
2.99 |
7.76 |
13 |
5.07 |
Annual Metrics And Ratios for SuRo Capital Corp. 6.00% Notes due 2026
This table displays calculated financial ratios and metrics derived from SuRo Capital Corp. 6.00% Notes due 2026's official financial filings.
| Metric |
|
2020 |
2021 |
2022 |
2023 |
2024 |
2025 |
| DEI Shares Outstanding |
|
0.00 |
0.00 |
28,333,661.00 |
25,209,108.00 |
- |
25,119,091.00 |
| DEI Adjusted Shares Outstanding |
|
0.00 |
0.00 |
28,333,661.00 |
25,209,108.00 |
- |
25,119,091.00 |
| DEI Earnings Per Adjusted Shares Outstanding |
|
0.00 |
0.00 |
-0.52 |
-0.53 |
- |
-0.66 |
| Growth Metrics |
|
- |
- |
- |
- |
- |
- |
| Revenue Growth |
|
0.00% |
447.15% |
134.98% |
90.87% |
-29.16% |
-63.92% |
| EBITDA Growth |
|
0.00% |
39.96% |
-45.18% |
8.14% |
-2.20% |
-19.52% |
| EBIT Growth |
|
0.00% |
40.75% |
-48.10% |
8.62% |
-3.81% |
-18.33% |
| NOPAT Growth |
|
0.00% |
31.58% |
-48.10% |
8.62% |
-3.81% |
-18.33% |
| Net Income Growth |
|
0.00% |
40.75% |
-48.10% |
8.62% |
-3.81% |
-18.33% |
| EPS Growth |
|
0.00% |
55.06% |
-179.71% |
104.32% |
-942.11% |
211.25% |
| Operating Cash Flow Growth |
|
0.00% |
877.38% |
-160.20% |
102.16% |
-0.56% |
1,348.30% |
| Free Cash Flow Firm Growth |
|
0.00% |
0.00% |
175.55% |
-100.33% |
1,276.86% |
-252.88% |
| Invested Capital Growth |
|
0.00% |
0.00% |
-76.82% |
-2.22% |
-16.70% |
19.18% |
| Revenue Q/Q Growth |
|
0.00% |
0.00% |
0.00% |
935.14% |
347.28% |
-28.39% |
| EBITDA Q/Q Growth |
|
0.00% |
0.00% |
0.00% |
27.92% |
21.86% |
-12.69% |
| EBIT Q/Q Growth |
|
0.00% |
0.00% |
0.00% |
27.44% |
21.13% |
-12.28% |
| NOPAT Q/Q Growth |
|
0.00% |
0.00% |
0.00% |
0.88% |
-8.74% |
-12.28% |
| Net Income Q/Q Growth |
|
0.00% |
0.00% |
0.00% |
27.44% |
21.13% |
-12.28% |
| EPS Q/Q Growth |
|
0.00% |
0.00% |
0.00% |
72.73% |
16.23% |
-26.75% |
| Operating Cash Flow Q/Q Growth |
|
0.00% |
0.00% |
-69.62% |
-95.05% |
107.78% |
96.45% |
| Free Cash Flow Firm Q/Q Growth |
|
0.00% |
0.00% |
0.00% |
0.00% |
-96.99% |
34.18% |
| Invested Capital Q/Q Growth |
|
0.00% |
0.00% |
0.00% |
-80.93% |
0.03% |
-9.89% |
| Profitability Metrics |
|
- |
- |
- |
- |
- |
- |
| EBITDA Margin |
|
-775.03% |
-668.84% |
-413.24% |
-198.89% |
-286.92% |
-950.39% |
| EBIT Margin |
|
-795.69% |
-675.18% |
-425.56% |
-203.73% |
-298.52% |
-978.99% |
| Profit (Net Income) Margin |
|
-795.69% |
-675.18% |
-425.56% |
-203.73% |
-298.52% |
-978.99% |
| Tax Burden Percent |
|
100.00% |
100.00% |
100.00% |
100.00% |
100.00% |
100.00% |
| Interest Burden Percent |
|
100.00% |
100.00% |
100.00% |
100.00% |
100.00% |
100.00% |
| Effective Tax Rate |
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
| Return on Invested Capital (ROIC) |
|
0.00% |
-1.14% |
-1.37% |
-3.36% |
-3.85% |
-4.57% |
| ROIC Less NNEP Spread (ROIC-NNEP) |
|
0.00% |
-1.67% |
-2.11% |
-8.84% |
-9.54% |
-11.49% |
| Return on Net Nonoperating Assets (RNNOA) |
|
0.00% |
-17.12% |
-4.36% |
-3.15% |
-3.89% |
-4.53% |
| Return on Equity (ROE) |
|
0.00% |
-18.25% |
-5.73% |
-6.50% |
-7.73% |
-9.10% |
| Cash Return on Invested Capital (CROIC) |
|
0.00% |
-201.14% |
123.36% |
-1.11% |
14.38% |
-22.07% |
| Operating Return on Assets (OROA) |
|
0.00% |
-0.81% |
-3.94% |
-4.78% |
-5.48% |
-6.50% |
| Return on Assets (ROA) |
|
0.00% |
-0.81% |
-3.94% |
-4.78% |
-5.48% |
-6.50% |
| Return on Common Equity (ROCE) |
|
0.00% |
-18.25% |
-5.73% |
-6.50% |
-7.73% |
-9.10% |
| Return on Equity Simple (ROE_SIMPLE) |
|
0.00% |
-9.13% |
-7.00% |
-6.61% |
-8.85% |
-8.04% |
| Net Operating Profit after Tax (NOPAT) |
|
-10 |
-6.95 |
-10 |
-9.41 |
-9.77 |
-12 |
| NOPAT Margin |
|
-556.98% |
-472.63% |
-297.89% |
-142.61% |
-208.97% |
-685.29% |
| Net Nonoperating Expense Percent (NNEP) |
|
0.00% |
0.54% |
0.74% |
5.48% |
5.69% |
6.93% |
| SG&A Expenses to Revenue |
|
482.52% |
418.99% |
218.92% |
143.75% |
195.99% |
523.74% |
| Operating Expenses to Revenue |
|
895.69% |
775.18% |
525.56% |
303.73% |
398.52% |
1,078.99% |
| Earnings before Interest and Taxes (EBIT) |
|
-15 |
-9.93 |
-15 |
-13 |
-14 |
-17 |
| Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA) |
|
-14 |
-9.84 |
-14 |
-13 |
-13 |
-16 |
| Valuation Ratios |
|
- |
- |
- |
- |
- |
- |
| Price to Book Value (P/BV) |
|
0.00 |
0.00 |
0.51 |
0.46 |
0.87 |
1.15 |
| Price to Tangible Book Value (P/TBV) |
|
0.00 |
0.00 |
0.51 |
0.46 |
0.87 |
1.15 |
| Price to Revenue (P/Rev) |
|
0.00 |
0.00 |
31.15 |
14.23 |
29.41 |
140.62 |
| Price to Earnings (P/E) |
|
0.00 |
0.00 |
0.00 |
18.52 |
0.00 |
4.86 |
| Dividend Yield |
|
8.79% |
29.30% |
88.42% |
0.00% |
0.00% |
5.30% |
| Earnings Yield |
|
0.00% |
0.00% |
0.00% |
5.40% |
0.00% |
20.58% |
| Enterprise Value to Invested Capital (EV/IC) |
|
0.00 |
0.00 |
0.50 |
0.50 |
0.83 |
0.94 |
| Enterprise Value to Revenue (EV/Rev) |
|
0.00 |
0.00 |
40.78 |
21.13 |
40.80 |
152.89 |
| Enterprise Value to EBITDA (EV/EBITDA) |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Enterprise Value to EBIT (EV/EBIT) |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Enterprise Value to NOPAT (EV/NOPAT) |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Enterprise Value to Operating Cash Flow (EV/OCF) |
|
0.00 |
0.00 |
0.00 |
58.50 |
80.47 |
7.51 |
| Enterprise Value to Free Cash Flow (EV/FCFF) |
|
0.00 |
0.00 |
0.15 |
0.00 |
5.22 |
0.00 |
| Leverage & Solvency |
|
- |
- |
- |
- |
- |
- |
| Debt to Equity |
|
0.00 |
0.00 |
0.35 |
0.36 |
0.46 |
0.34 |
| Long-Term Debt to Equity |
|
0.00 |
0.00 |
0.35 |
0.36 |
0.46 |
0.34 |
| Financial Leverage |
|
0.00 |
10.24 |
2.07 |
0.36 |
0.41 |
0.39 |
| Leverage Ratio |
|
0.00 |
11.24 |
1.30 |
1.36 |
1.41 |
1.40 |
| Compound Leverage Factor |
|
0.00 |
11.24 |
1.30 |
1.36 |
1.41 |
1.40 |
| Debt to Total Capital |
|
0.00% |
0.00% |
25.89% |
26.61% |
31.73% |
25.36% |
| Short-Term Debt to Total Capital |
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
| Long-Term Debt to Total Capital |
|
0.00% |
0.00% |
25.89% |
26.61% |
31.73% |
25.36% |
| Preferred Equity to Total Capital |
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
| Noncontrolling Interests to Total Capital |
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
| Common Equity to Total Capital |
|
0.00% |
100.00% |
74.11% |
73.39% |
68.27% |
74.64% |
| Debt to EBITDA |
|
0.00 |
0.00 |
-5.14 |
-5.62 |
-5.46 |
-4.35 |
| Net Debt to EBITDA |
|
0.00 |
0.00 |
-2.33 |
-3.47 |
-3.97 |
-1.29 |
| Long-Term Debt to EBITDA |
|
0.00 |
0.00 |
-5.14 |
-5.62 |
-5.46 |
-4.35 |
| Debt to NOPAT |
|
0.00 |
0.00 |
-7.13 |
-7.84 |
-7.50 |
-6.04 |
| Net Debt to NOPAT |
|
0.00 |
0.00 |
-3.23 |
-4.84 |
-5.45 |
-1.79 |
| Long-Term Debt to NOPAT |
|
0.00 |
0.00 |
-7.13 |
-7.84 |
-7.50 |
-6.04 |
| Noncontrolling Interest Sharing Ratio |
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
| Liquidity Ratios |
|
- |
- |
- |
- |
- |
- |
| Cash Flow Metrics |
|
- |
- |
- |
- |
- |
- |
| Free Cash Flow to Firm (FCFF) |
|
0.00 |
-1,230 |
929 |
-3.10 |
37 |
-56 |
| Operating Cash Flow to CapEx |
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
| Free Cash Flow to Firm to Interest Expense |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Operating Cash Flow to Interest Expense |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Operating Cash Flow Less CapEx to Interest Expense |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Efficiency Ratios |
|
- |
- |
- |
- |
- |
- |
| Asset Turnover |
|
0.00 |
0.00 |
0.01 |
0.02 |
0.02 |
0.01 |
| Fixed Asset Turnover |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Capital & Investment Metrics |
|
- |
- |
- |
- |
- |
- |
| Invested Capital |
|
0.00 |
1,223 |
283 |
277 |
231 |
275 |
| Invested Capital Turnover |
|
0.00 |
0.00 |
0.00 |
0.02 |
0.02 |
0.01 |
| Increase / (Decrease) in Invested Capital |
|
0.00 |
1,223 |
-939 |
-6.31 |
-46 |
44 |
| Enterprise Value (EV) |
|
0.00 |
0.00 |
141 |
139 |
191 |
258 |
| Market Capitalization |
|
0.00 |
0.00 |
108 |
94 |
137 |
237 |
| Book Value per Share |
|
$0.00 |
$4.21 |
$7.41 |
$8.07 |
$6.74 |
$8.17 |
| Tangible Book Value per Share |
|
$0.00 |
$4.21 |
$7.41 |
$8.07 |
$6.74 |
$8.17 |
| Total Capital |
|
0.00 |
109 |
283 |
277 |
231 |
275 |
| Total Debt |
|
0.00 |
0.00 |
73 |
74 |
73 |
70 |
| Total Long-Term Debt |
|
0.00 |
0.00 |
73 |
74 |
73 |
70 |
| Net Debt |
|
0.00 |
0.00 |
33 |
46 |
53 |
21 |
| Capital Expenditures (CapEx) |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Net Nonoperating Expense (NNE) |
|
4.35 |
2.98 |
4.41 |
4.03 |
4.19 |
4.95 |
| Net Nonoperating Obligations (NNO) |
|
0.00 |
1,114 |
73 |
74 |
73 |
70 |
| Total Depreciation and Amortization (D&A) |
|
0.38 |
0.09 |
0.43 |
0.32 |
0.54 |
0.48 |
| Earnings Adjustments |
|
- |
- |
- |
- |
- |
- |
| Adjusted Basic Earnings per Share |
|
$0.00 |
$0.00 |
$0.00 |
$0.19 |
($1.60) |
$2.01 |
| Adjusted Weighted Average Basic Shares Outstanding |
|
0.00 |
0.00 |
0.00 |
26.22M |
23.90M |
24.23M |
| Adjusted Diluted Earnings per Share |
|
$0.00 |
$0.00 |
$0.00 |
$0.19 |
($1.60) |
$1.78 |
| Adjusted Weighted Average Diluted Shares Outstanding |
|
0.00 |
0.00 |
0.00 |
26.22M |
23.90M |
28.79M |
| Adjusted Basic & Diluted Earnings per Share |
|
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Adjusted Weighted Average Basic & Diluted Shares Outstanding |
|
0.00 |
0.00 |
0.00 |
25.35M |
23.55M |
25.39M |
| Normalized Net Operating Profit after Tax (NOPAT) |
|
-10 |
-6.95 |
-10 |
-9.41 |
-9.77 |
-12 |
| Normalized NOPAT Margin |
|
-556.98% |
-472.63% |
-297.89% |
-142.61% |
-208.97% |
-685.29% |
| Pre Tax Income Margin |
|
-795.69% |
-675.18% |
-425.56% |
-203.73% |
-298.52% |
-978.99% |
| Debt Service Ratios |
|
- |
- |
- |
- |
- |
- |
| EBIT to Interest Expense |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| NOPAT to Interest Expense |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| EBIT Less CapEx to Interest Expense |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| NOPAT Less CapEx to Interest Expense |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Payout Ratios |
|
- |
- |
- |
- |
- |
- |
| Dividend Payout Ratio |
|
-101.00% |
-1,041.79% |
-180.42% |
-1.07% |
-1.03% |
-72.45% |
| Augmented Payout Ratio |
|
-172.52% |
-1,041.79% |
-326.27% |
-106.57% |
-68.41% |
-72.45% |
Quarterly Metrics And Ratios for SuRo Capital Corp. 6.00% Notes due 2026
This table displays calculated financial ratios and metrics derived from SuRo Capital Corp. 6.00% Notes due 2026's official financial filings.
| Metric |
|
Q1 2024 |
Q2 2024 |
Q3 2024 |
Q4 2024 |
Q1 2025 |
Q2 2025 |
Q3 2025 |
Q4 2025 |
Q1 2026 |
Q2 2026 |
Q3 2026 |
| DEI Shares Outstanding |
|
25,353,284.00 |
23,353,284.00 |
23,378,002.00 |
- |
23,551,859.00 |
23,551,859.00 |
23,888,107.00 |
25,119,091.00 |
25,387,756.00 |
26,070,208.00 |
26,473,222.00 |
| DEI Adjusted Shares Outstanding |
|
25,353,284.00 |
23,353,284.00 |
23,378,002.00 |
- |
23,551,859.00 |
23,551,859.00 |
23,888,107.00 |
25,119,091.00 |
25,387,756.00 |
26,070,208.00 |
26,473,222.00 |
| DEI Earnings Per Adjusted Shares Outstanding |
|
-0.13 |
-0.16 |
-0.14 |
- |
-0.16 |
-0.16 |
-0.14 |
-0.23 |
-0.16 |
-0.90 |
-0.90 |
| Growth Metrics |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
| Revenue Growth |
|
17.63% |
-25.13% |
-39.37% |
-50.02% |
-67.34% |
-83.72% |
-48.32% |
-54.39% |
46.66% |
79.11% |
-360.29% |
| EBITDA Growth |
|
24.29% |
6.72% |
-15.36% |
-41.99% |
-13.68% |
-1.47% |
-11.14% |
-48.20% |
-9.08% |
-545.48% |
-913.32% |
| EBIT Growth |
|
23.66% |
3.93% |
-20.22% |
-40.84% |
-13.62% |
-1.82% |
-7.70% |
-46.70% |
-8.65% |
-527.45% |
-953.13% |
| NOPAT Growth |
|
23.66% |
3.93% |
-20.22% |
-40.84% |
-13.62% |
-1.82% |
-7.70% |
-46.70% |
-8.65% |
-527.45% |
-697.19% |
| Net Income Growth |
|
23.66% |
3.93% |
-20.22% |
-40.84% |
-13.62% |
-1.82% |
-7.70% |
-46.70% |
-8.65% |
-527.45% |
-953.13% |
| EPS Growth |
|
-643.75% |
25.00% |
-123.23% |
86.11% |
96.55% |
595.56% |
221.74% |
-1,300.00% |
17,366.67% |
-132.29% |
-385.71% |
| Operating Cash Flow Growth |
|
180.65% |
0.00% |
-142.09% |
72.52% |
-116.35% |
160.21% |
99.52% |
135.37% |
-54.79% |
-171.41% |
8,273.60% |
| Free Cash Flow Firm Growth |
|
181.08% |
179.26% |
632.79% |
893.92% |
-97.95% |
-106.41% |
-106.31% |
-210.70% |
-990.18% |
-139.39% |
-50.90% |
| Invested Capital Growth |
|
-81.41% |
-79.66% |
-84.12% |
-16.70% |
-9.98% |
23.93% |
32.29% |
19.18% |
87.53% |
42.78% |
30.02% |
| Revenue Q/Q Growth |
|
-37.88% |
-32.77% |
-13.49% |
38.32% |
-59.40% |
-66.48% |
174.51% |
22.07% |
30.56% |
-59.06% |
-6,526.30% |
| EBITDA Q/Q Growth |
|
-18.20% |
-13.88% |
15.52% |
-24.85% |
5.36% |
-1.65% |
7.46% |
-66.49% |
30.34% |
-501.48% |
-1.55% |
| EBIT Q/Q Growth |
|
-17.45% |
-13.43% |
12.25% |
-20.48% |
5.26% |
-1.65% |
7.18% |
-64.12% |
29.83% |
-487.02% |
-1.58% |
| NOPAT Q/Q Growth |
|
-17.45% |
-13.43% |
12.25% |
-20.48% |
5.26% |
-1.65% |
7.18% |
-64.12% |
29.83% |
-487.02% |
-1.58% |
| Net Income Q/Q Growth |
|
-17.45% |
-13.43% |
12.25% |
-20.48% |
5.26% |
-1.65% |
7.18% |
-64.12% |
29.83% |
-487.02% |
-1.58% |
| EPS Q/Q Growth |
|
-141.67% |
48.28% |
48.89% |
78.26% |
40.00% |
7,533.33% |
-87.44% |
-350.00% |
840.00% |
-113.90% |
-11.11% |
| Operating Cash Flow Q/Q Growth |
|
150.22% |
-42.99% |
-261.14% |
40.42% |
70.12% |
1,007.14% |
-100.30% |
4,471.31% |
-230.77% |
-318.48% |
134.17% |
| Free Cash Flow Firm Q/Q Growth |
|
25,382.42% |
-17.40% |
32.17% |
-96.43% |
-47.37% |
-357.89% |
-30.07% |
37.30% |
-323.24% |
30.65% |
23.55% |
| Invested Capital Q/Q Growth |
|
-7.78% |
-7.56% |
-2.32% |
0.03% |
-0.33% |
27.26% |
4.27% |
-9.89% |
56.83% |
-3.11% |
-5.05% |
| Profitability Metrics |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
| EBITDA Margin |
|
-203.97% |
-345.50% |
-337.42% |
-304.57% |
-709.93% |
-2,152.70% |
-725.69% |
-989.73% |
-528.03% |
-7,758.13% |
0.00% |
| EBIT Margin |
|
-210.91% |
-355.83% |
-360.96% |
-314.41% |
-733.68% |
-2,224.79% |
-752.24% |
-1,011.34% |
-543.54% |
-7,793.99% |
0.00% |
| Profit (Net Income) Margin |
|
-210.91% |
-355.83% |
-360.96% |
-314.41% |
-733.68% |
-2,224.79% |
-752.24% |
-1,011.34% |
-543.54% |
-7,793.99% |
0.00% |
| Tax Burden Percent |
|
100.00% |
100.00% |
100.00% |
100.00% |
100.00% |
100.00% |
100.00% |
100.00% |
100.00% |
100.00% |
100.00% |
| Interest Burden Percent |
|
100.00% |
100.00% |
100.00% |
100.00% |
100.00% |
100.00% |
100.00% |
100.00% |
100.00% |
100.00% |
100.00% |
| Effective Tax Rate |
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
| Return on Invested Capital (ROIC) |
|
-1.24% |
-2.31% |
-1.77% |
-4.05% |
-7.71% |
-16.39% |
-4.63% |
-4.72% |
-2.21% |
-31.49% |
0.00% |
| ROIC Less NNEP Spread (ROIC-NNEP) |
|
-1.39% |
-2.52% |
-1.91% |
-5.63% |
-9.20% |
-17.91% |
-6.04% |
-7.10% |
-3.88% |
-41.83% |
0.00% |
| Return on Net Nonoperating Assets (RNNOA) |
|
-4.38% |
-7.52% |
-7.18% |
-2.29% |
-4.00% |
-6.91% |
-2.28% |
-2.80% |
-1.07% |
-9.86% |
0.00% |
| Return on Equity (ROE) |
|
-5.61% |
-9.83% |
-8.95% |
-6.34% |
-11.71% |
-23.30% |
-6.90% |
-7.52% |
-3.28% |
-41.35% |
-22.23% |
| Cash Return on Invested Capital (CROIC) |
|
136.24% |
131.17% |
144.10% |
14.38% |
6.35% |
-25.20% |
-31.64% |
-22.07% |
-64.45% |
-42.42% |
-38.66% |
| Operating Return on Assets (OROA) |
|
-5.25% |
-9.20% |
-8.15% |
-5.77% |
-10.95% |
-23.23% |
-6.54% |
-6.72% |
-3.14% |
-44.71% |
0.00% |
| Return on Assets (ROA) |
|
-5.25% |
-9.20% |
-8.15% |
-5.77% |
-10.95% |
-23.23% |
-6.54% |
-6.72% |
-3.14% |
-44.71% |
0.00% |
| Return on Common Equity (ROCE) |
|
-5.61% |
-9.83% |
-8.95% |
-6.34% |
-11.71% |
-23.30% |
-6.90% |
-7.52% |
-3.28% |
-41.35% |
-22.23% |
| Return on Equity Simple (ROE_SIMPLE) |
|
-6.85% |
-7.57% |
-8.15% |
0.00% |
-9.18% |
-6.59% |
-6.34% |
0.00% |
-4.65% |
-10.25% |
-18.81% |
| Net Operating Profit after Tax (NOPAT) |
|
-2.26 |
-2.56 |
-2.25 |
-2.71 |
-2.56 |
-2.61 |
-2.42 |
-3.97 |
-2.78 |
-16 |
-17 |
| NOPAT Margin |
|
-147.64% |
-249.08% |
-252.67% |
-220.08% |
-513.58% |
-1,557.35% |
-526.57% |
-707.94% |
-380.48% |
-5,455.79% |
0.00% |
| Net Nonoperating Expense Percent (NNEP) |
|
0.15% |
0.21% |
0.14% |
1.58% |
1.49% |
1.52% |
1.41% |
2.38% |
1.67% |
10.34% |
10.49% |
| SG&A Expenses to Revenue |
|
143.01% |
214.00% |
215.63% |
232.62% |
334.17% |
939.52% |
365.47% |
698.07% |
269.99% |
6,573.11% |
0.00% |
| Operating Expenses to Revenue |
|
310.91% |
455.83% |
460.96% |
414.41% |
833.68% |
2,324.79% |
852.24% |
1,111.34% |
643.54% |
7,893.99% |
0.00% |
| Earnings before Interest and Taxes (EBIT) |
|
-3.22 |
-3.66 |
-3.21 |
-3.86 |
-3.66 |
-3.72 |
-3.45 |
-5.67 |
-3.98 |
-23 |
-24 |
| Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA) |
|
-3.12 |
-3.55 |
-3.00 |
-3.74 |
-3.54 |
-3.60 |
-3.33 |
-5.55 |
-3.87 |
-23 |
-24 |
| Valuation Ratios |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
| Price to Book Value (P/BV) |
|
0.63 |
0.56 |
0.58 |
0.87 |
0.71 |
0.86 |
0.93 |
1.15 |
0.75 |
0.92 |
0.61 |
| Price to Tangible Book Value (P/TBV) |
|
0.63 |
0.56 |
0.58 |
0.87 |
0.71 |
0.86 |
0.93 |
1.15 |
0.75 |
0.92 |
0.61 |
| Price to Revenue (P/Rev) |
|
16.90 |
14.04 |
15.55 |
29.41 |
30.35 |
67.50 |
91.29 |
140.62 |
141.68 |
159.36 |
0.00 |
| Price to Earnings (P/E) |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
3.35 |
3.12 |
4.86 |
1.32 |
2.63 |
2.08 |
| Dividend Yield |
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
2.78% |
5.30% |
4.67% |
3.99% |
6.50% |
| Earnings Yield |
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
29.86% |
32.09% |
20.58% |
75.49% |
38.00% |
48.00% |
| Enterprise Value to Invested Capital (EV/IC) |
|
0.54 |
0.47 |
0.57 |
0.83 |
0.73 |
0.72 |
0.77 |
0.94 |
0.69 |
0.90 |
0.57 |
| Enterprise Value to Revenue (EV/Rev) |
|
20.27 |
17.06 |
22.42 |
40.80 |
46.01 |
75.93 |
99.32 |
152.89 |
155.52 |
183.35 |
0.00 |
| Enterprise Value to EBITDA (EV/EBITDA) |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Enterprise Value to EBIT (EV/EBIT) |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Enterprise Value to NOPAT (EV/NOPAT) |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Enterprise Value to Operating Cash Flow (EV/OCF) |
|
8.13 |
2.76 |
0.00 |
80.47 |
0.00 |
0.00 |
13.39 |
7.51 |
9.25 |
0.00 |
0.00 |
| Enterprise Value to Free Cash Flow (EV/FCFF) |
|
0.12 |
0.12 |
0.11 |
5.22 |
10.87 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Leverage & Solvency |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
| Debt to Equity |
|
0.41 |
0.46 |
0.47 |
0.46 |
0.47 |
0.33 |
0.32 |
0.34 |
0.19 |
0.17 |
0.19 |
| Long-Term Debt to Equity |
|
0.41 |
0.46 |
0.47 |
0.46 |
0.47 |
0.33 |
0.32 |
0.34 |
0.19 |
0.17 |
0.19 |
| Financial Leverage |
|
3.15 |
2.98 |
3.76 |
0.41 |
0.43 |
0.39 |
0.38 |
0.39 |
0.28 |
0.24 |
0.24 |
| Leverage Ratio |
|
1.38 |
1.44 |
1.42 |
1.41 |
1.44 |
1.40 |
1.39 |
1.40 |
1.28 |
1.24 |
1.28 |
| Compound Leverage Factor |
|
1.38 |
1.44 |
1.42 |
1.41 |
1.44 |
1.40 |
1.39 |
1.40 |
1.28 |
1.24 |
1.28 |
| Debt to Total Capital |
|
28.89% |
31.29% |
31.77% |
31.73% |
31.84% |
25.06% |
24.07% |
25.36% |
16.20% |
14.87% |
15.67% |
| Short-Term Debt to Total Capital |
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
| Long-Term Debt to Total Capital |
|
28.89% |
31.29% |
31.77% |
31.73% |
31.84% |
25.06% |
24.07% |
25.36% |
16.20% |
14.87% |
15.67% |
| Preferred Equity to Total Capital |
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
| Noncontrolling Interests to Total Capital |
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
| Common Equity to Total Capital |
|
71.11% |
68.71% |
68.23% |
68.27% |
68.16% |
74.94% |
75.93% |
74.64% |
83.80% |
85.13% |
84.33% |
| Debt to EBITDA |
|
-6.09 |
-6.21 |
-5.96 |
-5.46 |
-5.29 |
-5.28 |
-5.17 |
-4.35 |
-4.27 |
-1.73 |
-1.00 |
| Net Debt to EBITDA |
|
-1.90 |
-1.64 |
-3.30 |
-3.97 |
-4.13 |
-1.69 |
-1.33 |
-1.29 |
-1.62 |
-1.37 |
-0.34 |
| Long-Term Debt to EBITDA |
|
-6.09 |
-6.21 |
-5.96 |
-5.46 |
-5.29 |
-5.28 |
-5.17 |
-4.35 |
-4.27 |
-1.73 |
-1.00 |
| Debt to NOPAT |
|
-8.48 |
-8.59 |
-8.16 |
-7.50 |
-7.27 |
-7.25 |
-7.14 |
-6.04 |
-5.93 |
-2.44 |
-1.41 |
| Net Debt to NOPAT |
|
-2.64 |
-2.27 |
-4.52 |
-5.45 |
-5.67 |
-2.32 |
-1.84 |
-1.79 |
-2.26 |
-1.93 |
-0.48 |
| Long-Term Debt to NOPAT |
|
-8.48 |
-8.59 |
-8.16 |
-7.50 |
-7.27 |
-7.25 |
-7.14 |
-6.04 |
-5.93 |
-2.44 |
-1.41 |
| Noncontrolling Interest Sharing Ratio |
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
| Liquidity Ratios |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
| Cash Flow Metrics |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
| Free Cash Flow to Firm (FCFF) |
|
1,117 |
923 |
1,220 |
44 |
23 |
-59 |
-77 |
-48 |
-204 |
-142 |
-108 |
| Operating Cash Flow to CapEx |
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
| Free Cash Flow to Firm to Interest Expense |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Operating Cash Flow to Interest Expense |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Operating Cash Flow Less CapEx to Interest Expense |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Efficiency Ratios |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
| Asset Turnover |
|
0.02 |
0.03 |
0.02 |
0.02 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.00 |
| Fixed Asset Turnover |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Capital & Investment Metrics |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
| Invested Capital |
|
256 |
236 |
231 |
231 |
230 |
293 |
305 |
275 |
431 |
418 |
397 |
| Invested Capital Turnover |
|
0.01 |
0.01 |
0.01 |
0.02 |
0.02 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.00 |
| Increase / (Decrease) in Invested Capital |
|
-1,119 |
-925 |
-1,222 |
-46 |
-25 |
57 |
75 |
44 |
201 |
125 |
92 |
| Enterprise Value (EV) |
|
138 |
111 |
132 |
191 |
168 |
211 |
234 |
258 |
298 |
376 |
225 |
| Market Capitalization |
|
115 |
91 |
92 |
137 |
111 |
188 |
215 |
237 |
272 |
327 |
204 |
| Book Value per Share |
|
$7.17 |
$6.95 |
$6.73 |
$6.74 |
$6.66 |
$9.32 |
$9.70 |
$8.17 |
$14.24 |
$13.65 |
$12.64 |
| Tangible Book Value per Share |
|
$7.17 |
$6.95 |
$6.73 |
$6.74 |
$6.66 |
$9.32 |
$9.70 |
$8.17 |
$14.24 |
$13.65 |
$12.64 |
| Total Capital |
|
256 |
236 |
231 |
231 |
230 |
293 |
305 |
275 |
431 |
418 |
397 |
| Total Debt |
|
74 |
74 |
73 |
73 |
73 |
73 |
73 |
70 |
70 |
62 |
62 |
| Total Long-Term Debt |
|
74 |
74 |
73 |
73 |
73 |
73 |
73 |
70 |
70 |
62 |
62 |
| Net Debt |
|
23 |
20 |
41 |
53 |
57 |
23 |
19 |
21 |
27 |
49 |
21 |
| Capital Expenditures (CapEx) |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Net Nonoperating Expense (NNE) |
|
0.97 |
1.10 |
0.96 |
1.16 |
1.10 |
1.12 |
1.04 |
1.70 |
1.19 |
7.01 |
7.12 |
| Net Nonoperating Obligations (NNO) |
|
74 |
74 |
73 |
73 |
73 |
73 |
73 |
70 |
70 |
62 |
62 |
| Total Depreciation and Amortization (D&A) |
|
0.11 |
0.11 |
0.21 |
0.12 |
0.12 |
0.12 |
0.12 |
0.12 |
0.11 |
0.11 |
0.11 |
| Earnings Adjustments |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
| Adjusted Basic Earnings per Share |
|
($0.87) |
($0.45) |
($0.23) |
($0.05) |
($0.03) |
$2.63 |
$0.30 |
($0.89) |
$6.13 |
($0.72) |
($0.80) |
| Adjusted Weighted Average Basic Shares Outstanding |
|
25.39M |
23.41M |
23.38M |
23.90M |
23.57M |
23.73M |
24.37M |
24.23M |
25.38M |
25.98M |
26.47M |
| Adjusted Diluted Earnings per Share |
|
($0.87) |
($0.45) |
($0.23) |
($0.05) |
($0.03) |
$2.23 |
$0.28 |
($0.70) |
$5.18 |
($0.72) |
($0.80) |
| Adjusted Weighted Average Diluted Shares Outstanding |
|
25.39M |
23.41M |
23.38M |
23.90M |
23.57M |
28.24M |
28.99M |
28.79M |
30.16M |
25.98M |
26.47M |
| Adjusted Basic & Diluted Earnings per Share |
|
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Adjusted Weighted Average Basic & Diluted Shares Outstanding |
|
23.35M |
23.38M |
23.38M |
23.55M |
23.55M |
23.89M |
25.12M |
25.39M |
26.07M |
26.47M |
26.47M |
| Normalized Net Operating Profit after Tax (NOPAT) |
|
-2.26 |
-2.56 |
-2.25 |
-2.71 |
-2.56 |
-2.61 |
-2.42 |
-3.97 |
-2.78 |
-16 |
-17 |
| Normalized NOPAT Margin |
|
-147.64% |
-249.08% |
-252.67% |
-220.08% |
-513.58% |
-1,557.35% |
-526.57% |
-707.94% |
-380.48% |
-5,455.79% |
0.00% |
| Pre Tax Income Margin |
|
-210.91% |
-355.83% |
-360.96% |
-314.41% |
-733.68% |
-2,224.79% |
-752.24% |
-1,011.34% |
-543.54% |
-7,793.99% |
0.00% |
| Debt Service Ratios |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
| EBIT to Interest Expense |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| NOPAT to Interest Expense |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| EBIT Less CapEx to Interest Expense |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| NOPAT Less CapEx to Interest Expense |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Payout Ratios |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
| Dividend Payout Ratio |
|
-1.15% |
-1.17% |
-1.12% |
-1.03% |
-0.31% |
-0.31% |
-39.67% |
-72.45% |
-71.04% |
-33.61% |
-10.27% |
| Augmented Payout Ratio |
|
-1.15% |
-83.17% |
-74.38% |
-68.41% |
-0.31% |
-0.31% |
-39.67% |
-72.45% |
-71.04% |
-49.79% |
-19.63% |
Key Financial Trends
Data identification warning: The supplied statements identify the company as Suro Capital Corp. (ticker: SSSS), not Neostellar Capital (NASDAQ:NSLR). The following analysis therefore describes the provided SSSS data and should not be attributed to NSLR without verifying the source.
Latest-quarter performance: In Q2 2026, revenue declined to $0.3 million from $0.7 million in Q1 2026 and $0.6 million in Q4 2025. At the same time, non-interest expense surged to $23.7 million, largely because salaries and employee benefits increased to $19.7 million from $2.0 million in Q1. The company reported a net loss attributable to common shareholders of $18.7 million, or $0.72 per diluted share, compared with net income of $155.6 million, or $5.18 per diluted share, in Q1. The Q1 profit was heavily influenced by a large adjustment rather than recurring operating revenue.
Cash flow and liquidity: Operating cash flow remained negative in Q2 2026 at -$24.1 million, following negative operating cash flow of $5.8 million in Q1. The company also used $6.3 million in financing cash flow, resulting in a quarterly cash decline of $30.4 million. Cash and due from banks fell to $12.9 million at June 30, 2026, from $43.3 million three months earlier and $54.5 million in Q3 2025.
Balance-sheet trends: Total assets declined to $420.1 million in Q2 2026 from $433.3 million in Q1, but remained substantially above $231.7 million in Q1 2025. Long-term debt decreased to $62.2 million from $69.9 million in Q1 2026 and $73.5 million in Q1 2025. Total liabilities represented approximately 15% of assets, while total equity remained sizable at $355.9 million. However, the sharp cash reduction and large concentration in “other assets,” which totaled $406.6 million, warrant closer review.
Multi-quarter context: The statements show recurring operating losses across most periods, with reported profits in some quarters driven by large non-operating or other adjustments. Revenue has generally remained below operating expenses. Cash flow was positive in Q2 2025 and Q4 2025, but turned negative in each quarter of 2026 provided. The data also includes restated periods and unusually large non-cash adjustments, making reported earnings less representative of underlying operating performance.
- Debt reduction: Long-term debt fell by approximately $7.7 million, or 11%, from Q1 2026 to Q2 2026.
- Strong equity cushion: Total equity of $355.9 million substantially exceeded total liabilities of $64.3 million at the end of Q2 2026.
- Asset growth over the longer period: Total assets increased from $231.7 million in Q1 2025 to $420.1 million in Q2 2026, although the composition of that growth should be investigated.
- Revenue volatility: Investment banking income increased from $0.2 million in Q2 2025 to $0.3 million in Q2 2026, but remained too small to cover operating expenses.
- Large accounting adjustments: Significant non-cash adjustments and other adjustments to net income have caused reported earnings to fluctuate sharply between quarters.
- Data-quality concern: The company name and ticker in the supplied filings do not match Neostellar Capital or NSLR, and several historical periods are marked as restated.
- Persistent operating losses: The company reported a $23.4 million pretax loss in Q2 2026, compared with losses of $4.0 million in Q1 2026 and $5.7 million in Q4 2025.
- Negative operating cash flow: Operating cash flow was negative for both Q1 and Q2 2026, totaling approximately $29.8 million of cash consumption during the first half of the year.
- Rapid cash depletion: Cash declined approximately 70% from $43.3 million at Q1 2026 quarter-end to $12.9 million at Q2 quarter-end.
- Expense pressure: Q2 2026 non-interest expense was nearly 79 times reported revenue, indicating that the current revenue base is insufficient to support the cost structure.
11/17/26 06:43 PM ETAI Generated. May Contain Errors.